换一批Exposure to rufinamide and risks of CNS adverse events in drug-resistant epilepsy: a meta-analysis of randomized, placebo-controlled trials.
第一作者：
Abdulaziz M S,Alsaad
第一单位：
Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada; Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh, KSA.
作者：
医学主题词
抗惊厥药(Anticonvulsants);中枢神经系统疾病(Central Nervous System Diseases);过度嗜睡性障碍(Disorders of Excessive Somnolence);头晕(Dizziness);抗药性(Drug Resistance);癫痫(Epilepsy);疲劳(Fatigue);头痛(Headache);人类(Humans);随机对照试验(主题)(Randomized Controlled Trials as Topic);危险(Risk);三唑类(Triazoles)
DOI
10.1111/bcp.12479
PMID
25132372
发布时间
2021-10-21
- 浏览73
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
